Back to Browse Journals » Clinical Oncology in Adolescents and Young Adults » Volume 2

What is a pediatric tumor?

Authors Mora J

Published Date November 2012 Volume 2012:2 Pages 7—15


Received 26 September 2012, Accepted 24 October 2012, Published 20 November 2012

Jaume Mora1,2

Department of Oncology, 2Developmental Tumor Biology Laboratory, Hospital Sant Joan de Deu, Fundacio Sant Joan de Deu, Barcelona, Spain

Abstract: Working together with medical oncologists, the question of whether a Ewing sarcoma in a 25-year-old is a pediatric tumor comes up repeatedly. Like Ewing's, some tumors present characteristically at ages that cross over what has been set as the definition of pediatrics (15 years, 18 years, or 21 years?). Pediatric oncology textbooks, surprisingly, do not address the subject of defining a pediatric tumor. They all begin with an epidemiology chapter defining the types of tumors appearing at distinct stages of childhood, adolescence, and young adulthood. Describing the epidemiology of tumors in relation to age, it becomes clear that the disease is related to the phenomenon of aging. The question, however, remains: is there a biological definition of what pediatric age is? And if so, will tumors occurring during this period of life have anything to do with such biological definition? With the aim of finding an objective definition, the fundamental concepts of what defines "pediatrics" was reviewed and then the major features of tumors arising during development were analyzed. The tumors were explored from the perspective of a host immersed in the normal process of growth and development. This physiological process, from pluripotential and undifferentiated cells, makes possible the differentiation, maturation, organization, and function of tissues, organs, and apparatus. A biological definition of pediatric tumors and the infancy–childhood–puberty classification of developmental tumors according to the infancy–childhood–puberty model of normal human development are proposed.

Keywords: growth and development, pediatric tumor, infant, childhood and adolescence, pubertal tumors

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at:

Readers of this article also read:

Untreated hepatocellular carcinoma in Egypt: outcome and prognostic factors

Zeeneldin AA, Salem SE, Darwish AD, El-Gammal MM, Hussein MM, Saadeldin M

Journal of Hepatocellular Carcinoma 2015, 2:3-9

Published Date: 30 January 2015

Which thiazide to choose as add-on therapy for hypertension?

Barrios V, Escobar C

Integrated Blood Pressure Control 2014, 7:35-47

Published Date: 30 July 2014

Treating resistant hypertension: role of renal denervation

Urban D, Ewen S, Ukena C, Linz D, Böhm M, Mahfoud F

Integrated Blood Pressure Control 2013, 6:119-128

Published Date: 11 September 2013

Outpatient chemotherapy, family-centered care, electronic information, and education in adolescents and young adults with osteosarcoma

Anderson P, Wells P, Lazarte T, Gore L, Salvador L, Salazar-Abshire M

Clinical Oncology in Adolescents and Young Adults 2013, 3:1-11

Published Date: 14 January 2013

Predicting response to incretin-based therapy

Kalra S, Kalra B, Sahay R, Agrawal N

Research and Reports in Endocrine Disorders 2011, 1:11-19

Published Date: 7 April 2011